| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 108.02M | — |
| Operating expense | — | — |
| Net income | 22.71M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RGNX returned +19.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -25.6% |
| 1 year | +19.0% |
| 5 years | -66.8% |
| 10 years | -8.5% |
| All-time high | $75.50 (Sep 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RGNX would be worth today ›No. REGENXBIO Inc. has not paid a dividend in the past 12 months.
REGENXBIO Inc. stock trades on NASDAQ under the ticker symbol RGNX.
REGENXBIO Inc. is part of the Healthcare sector.
REGENXBIO Inc. has a market cap of 707.66M USD, based on the latest quote.
REGENXBIO Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
